$TMO News

Cell and Gene Therapy Contract Research Organization Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, IQVIA, Labcorp, ICON, and WuXi AppTec Scale Integrated Trials

Thermo Fisher Scientific (TMO) Benefits on Broad-Based Recovery Across Life-Science Markets

Citigroup Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $800

Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $775

RBC Capital Maintains Sector Perform on Thermo Fisher Scientific, Raises Price Target to $730

TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $810

Stifel Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $775

TMO Q3 deep dive: pharma demand, AI integration, and end-market recovery drive momentum

Baird Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $756

Thermo Fisher Scientific (TMO) Stock Faces A Q3 Earnings Disconnect

Thermo Fisher Scientific Inc. Reports Third Quarter 2026 Results

Thermo Fisher Stock Shrugs Off a Beat: Here’s What It Looks Like Without Tariff Refunds

Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors

Thermo Fisher (TMO) Q3 2026 Earnings Call Transcript

Thermo Fisher Scientific Inc. Q3 2026 Earnings Call Summary

Thermo Fisher Scientific Highlights Continued Strong Customer Activity

Thermo Fisher Scientific Q3 Earnings Call Highlights

Thermo Fisher Scientific Reports 9% Revenue Growth as Third-Quarter Earnings Beat Estimates

Thermo Fisher posts higher third-quarter revenue and earnings as margins improve

Thermo Fisher Slides Despite Third-Quarter Beat — Here's What Happened